Skip to main navigation
  • Investor Home
  • News & Presentations
    News Events Presentations
  • Governance
    Governance Overview Board of Directors Leadership Our ESG Philosophy
  • Financials
    SEC Filings Quarterly Results Annual Reports
  • Stock Information
    Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
  • Resources
    Pipeline Investor FAQs Email Alerts Contact IR

Presentations


Featured Presentation

Arcutis Fourth Quarter 2025 Financial Results & Business Update 1.6 MB
Arcutis January 2026 Corporate Presentation 1.8 MB
December 9, 2020
Arcutis 2020 Virtual Investor Day
November 23, 2020
Phase 2b Study of Roflumilast Foam in Adolescents and Adults with Scalp and Body Psoriasis
September 29, 2020
Arcutis Roflumilast Foam Seb Derm Patient Needs Infographic
September 29, 2020
Arcutis Roflumilast Foam Seb Derm Patient Impact Infographic
September 29, 2020
Arcutis Phase 2 Seborrheic Dermatitis Topline Data Call
September 29, 2020
Arcutis Roflumilast Foam Seb Derm Trial and Data Infographic
  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
Print Page
RSS Feeds
Email Alerts
Search
Arcutis Biotherapeutics logo

© 2026 Arcutis Biotherapeutics, Inc. All rights reserved.

  • Image of the Linkedin Logo
  • Image of the Twitter Logo
  • Image of the Instagram Logo
  • Contact
  • Legal Disclaimer
  • Privacy Notice
  • Consumer Health Data Privacy Policy
  • Your Privacy Choices
  • Cookies Settings

© 2026 Arcutis Biotherapeutics, Inc. All rights reserved.